A carregar...

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.

An agonist analogue of luteinising hormone releasing hormone (buserelin) was successfully used to treat women with endometriosis. A dose of 200 micrograms administered intranasally thrice daily was found to be effective in five patients, in whom the endometriotic lesions resolved after six months�...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shaw, R W, Fraser, H M, Boyle, H
Formato: Artigo
Idioma:Inglês
Publicado em: 1983
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1550136/
https://ncbi.nlm.nih.gov/pubmed/6416542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!